30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Vera Therapeutics Inc (VERA)

Track

Over the last 90 days, Vera Therapeutics Inc. has seen 7 insider transactions, all of which were sales totaling over $3.37 million. Notably, President and CEO Marshall Fordyce and Director/Officer Marshall Fordyce executed multiple planned and proposed sales. The company's stock has declined approximately 16% over the past 90 days.
Stock chart
Ticker: VERA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Fordyce Marshall
PRESIDENT AND CEO
2 sales — total 679,747 USD
Planned sale 12 May 2026
Value US$688,195.27 | Price 318.13 | Shares 62,468
Planned sale 12 May 2026
Value US$1,147,231.22 | Price 326.22 | Shares 19,388
Proposed sale 12 May 2026
Value US$1,331,997.15 | Price 324.96 | Shares 87,427
Planned sale 14 Apr 2026
Value US$40,960.26 | Price 45.51 | Shares 900
Planned sale 14 Apr 2026
Value US$353,105.51 | Price 44.58 | Shares 7,921
Planned sale 14 Apr 2026
Value US$616,985.04 | Price 43.66 | Shares 14,130
Proposed sale 14 Apr 2026
Value US$1,003,188.21 | Price 43.71 | Shares 22,951
Sale 23 Feb 2026
Value US$90,307.37 | Price 41.98 | Shares 2,151
Sale 23 Feb 2026
Value US$130,863.82 | Price 41.98 | Shares 3,117
Sale 23 Feb 2026
Value US$207,778.32 | Price 41.98 | Shares 4,949
Sale 23 Feb 2026
Value US$710,577.51 | Price 41.98 | Shares 16,925
Sale 23 Feb 2026
Value US$108,276.48 | Price 41.98 | Shares 2,579
Sale 23 Feb 2026
Value US$91,818.79 | Price 41.98 | Shares 2,187
Sale 23 Feb 2026
Value US$66,418.53 | Price 41.98 | Shares 1,582
Proposed sale 23 Feb 2026
Value US$75,663.00 | Price 42.04 | Shares 1,800
Proposed sale 23 Feb 2026
Value US$109,291.00 | Price 42.04 | Shares 2,600
Proposed sale 23 Feb 2026
Value US$239,599.50 | Price 42.04 | Shares 5,700
Proposed sale 23 Feb 2026
Value US$105,087.50 | Price 42.04 | Shares 2,500
Proposed sale 23 Feb 2026
Value US$121,901.50 | Price 42.04 | Shares 2,900
Proposed sale 23 Feb 2026
Value US$697,781.00 | Price 42.04 | Shares 16,600
Planned sale 15 Dec 2025
Value US$500,767.00 | Price 50.08 | Shares 10,000
Proposed sale 15 Dec 2025
Value US$498,000.00 | Price 49.80 | Shares 10,000
Buy 11 Dec 2025
Value US$249,985.00 | Price 42.50 | Shares 5,882
Planned sale 8 Dec 2025
Value US$453,053.00 | Price 45.31 | Shares 10,000
Proposed sale 8 Dec 2025
Value US$449,000.00 | Price 44.90 | Shares 10,000
Planned sale 3 Dec 2025
Value US$400,000.00 | Price 40.00 | Shares 10,000
Sale 21 Nov 2025
Value US$107,498.03 | Price 27.82 | Shares 3,864
Proposed sale 21 Nov 2025
Value US$107,689.68 | Price 27.87 | Shares 3,864
Planned sale 11 Nov 2025
Value US$435,874.50 | Price 29.06 | Shares 15,000
Buy 24 Jun 2025
Value US$605,082.87 | Price 22.35 | Shares 27,071
Buy 24 Jun 2025
Value US$302,552.61 | Price 22.35 | Shares 13,536
Buy 23 Jun 2025
Value US$2,913,110.34 | Price 20.87 | Shares 139,595
Buy 23 Jun 2025
Value US$1,456,565.60 | Price 20.87 | Shares 69,798
Planned sale 26 Feb 2025
Value US$31,150.13 | Price 28.32 | Shares 1,100
Planned sale 26 Feb 2025
Value US$219,731.98 | Price 27.55 | Shares 7,975
Proposed sale 26 Feb 2025
Value US$245,932.50 | Price 27.10 | Shares 9,075
Planned sale 21 Feb 2025
Value US$296,031.59 | Price 27.89 | Shares 10,613
Planned sale 8 Jan 2025
Value US$78,750.00 | Price 42.00 | Shares 1,875
Planned sale 8 Jan 2025
Value US$237,488.71 | Price 42.03 | Shares 5,650
Planned sale 8 Jan 2025
Value US$414,296.66 | Price 41.53 | Shares 9,975
Proposed sale 8 Jan 2025
Value US$736,750.00 | Price 42.10 | Shares 17,500
Planned sale 18 Dec 2024
Value US$82,143.75 | Price 43.81 | Shares 1,875
Planned sale 18 Dec 2024
Value US$204,093.88 | Price 44.03 | Shares 4,635
Planned sale 18 Dec 2024
Value US$218,609.50 | Price 43.52 | Shares 5,023
Planned sale 18 Dec 2024
Value US$92,949.25 | Price 42.35 | Shares 2,195
Planned sale 18 Dec 2024
Value US$155,883.18 | Price 41.33 | Shares 3,772
Proposed sale 18 Dec 2024
Value US$768,425.00 | Price 43.91 | Shares 17,500
Planned sale 11 Dec 2024
Value US$4,765.00 | Price 47.65 | Shares 100
Planned sale 11 Dec 2024
Value US$83,324.89 | Price 46.94 | Shares 1,775
Planned sale 11 Dec 2024
Value US$33,283.74 | Price 47.55 | Shares 700
Planned sale 11 Dec 2024
Value US$700,149.66 | Price 46.91 | Shares 14,925
Proposed sale 11 Dec 2024
Value US$821,100.00 | Price 46.92 | Shares 17,500
Planned sale 25 Nov 2024
Value US$91,875.00 | Price 49.00 | Shares 1,875
Planned sale 25 Nov 2024
Value US$91,425.00 | Price 48.76 | Shares 1,875
Planned sale 25 Nov 2024
Value US$67,398.60 | Price 48.80 | Shares 1,381
Planned sale 25 Nov 2024
Value US$369,329.59 | Price 48.18 | Shares 7,665
Planned sale 25 Nov 2024
Value US$309,532.08 | Price 47.05 | Shares 6,579
Proposed sale 25 Nov 2024
Value US$936,006.25 | Price 48.31 | Shares 19,375
Planned sale 13 Nov 2024
Value US$367,500.00 | Price 49.00 | Shares 7,500
Planned sale 13 Nov 2024
Value US$92,811.00 | Price 49.50 | Shares 1,875
Planned sale 13 Nov 2024
Value US$92,848.50 | Price 49.52 | Shares 1,875
Planned sale 13 Nov 2024
Value US$92,951.06 | Price 49.57 | Shares 1,875
Planned sale 13 Nov 2024
Value US$15,608.81 | Price 50.35 | Shares 310
Planned sale 13 Nov 2024
Value US$77,603.19 | Price 49.59 | Shares 1,565
Planned sale 13 Nov 2024
Value US$5,120.00 | Price 51.20 | Shares 100
Planned sale 13 Nov 2024
Value US$166,280.92 | Price 50.28 | Shares 3,307
Planned sale 13 Nov 2024
Value US$605,313.93 | Price 49.54 | Shares 12,218
Proposed sale 13 Nov 2024
Value US$1,486,537.50 | Price 48.54 | Shares 30,625
Planned sale 28 Oct 2024
Value US$10,007.20 | Price 49.54 | Shares 202
Planned sale 28 Oct 2024
Value US$710,486.02 | Price 48.01 | Shares 14,798
Proposed sale 28 Oct 2024
Value US$616,350.00 | Price 41.09 | Shares 15,000
Planned sale 23 Oct 2024
Value US$157,500.00 | Price 42.00 | Shares 3,750
Planned sale 23 Oct 2024
Value US$24,967.62 | Price 41.61 | Shares 600
Planned sale 23 Oct 2024
Value US$94,022.08 | Price 40.70 | Shares 2,310
Planned sale 23 Oct 2024
Value US$506,120.58 | Price 39.81 | Shares 12,715
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-13 2026-05-12 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
62,468 -12.0%
318.13
US$688,195 		62,468 -12.0% 318.13 US$688,195
2026-05-13 2026-05-12 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
19,388 -10.2%
326.22
US$1,147,231 		19,388 -10.2% 326.22 US$1,147,231
2026-05-12 2026-05-12 PrS Proposed sale
MARSHALL FORDYCE

Director; Officer

Executive Director
87,427
324.96
US$1,331,997 		87,427 324.96 US$1,331,997
2026-04-15 2026-04-14 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
900 -0.4%
45.51
US$40,960 		900 -0.4% 45.51 US$40,960
2026-04-15 2026-04-14 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
7,921 -3.2%
44.58
US$353,106 		7,921 -3.2% 44.58 US$353,106
2026-04-15 2026-04-14 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
14,130 -5.5%
43.66
US$616,985 		14,130 -5.5% 43.66 US$616,985
2026-04-14 2026-04-14 PrS Proposed sale
MARSHALL FORDYCE

Director; Officer

Executive Director
22,951
43.71
US$1,003,188 		22,951 43.71 US$1,003,188
2026-02-25 2026-02-23 S Sale
Brenner Robert

Chief Medical Officer

Officer
2,151 -4.1%
41.98
US$90,307 		2,151 -4.1% 41.98 US$90,307
2026-02-25 2026-02-23 S Sale
3.6
Young Joseph R

SVP, FINANCE, CHIEF ACCT OFFCR

Officer
3,117 -4.6%
41.98
US$130,864 		3,117 -4.6% 41.98 US$130,864
2026-02-25 2026-02-23 S Sale
3.0
Grant Sean

CHIEF FINANCIAL OFFICER

Officer
4,949 -4.2%
41.98
US$207,778 		4,949 -4.2% 41.98 US$207,778
2026-02-25 2026-02-23 S Sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
16,925 -6.2%
41.98
US$710,578 		16,925 -6.2% 41.98 US$710,578
2026-02-25 2026-02-23 S Sale
JOHNSON DAVID LEE

Chief Operating Officer

Officer
2,579 -5.3%
41.98
US$108,276 		2,579 -5.3% 41.98 US$108,276
2026-02-25 2026-02-23 S Sale
Turner William D.

Chief Regulatory Officer

Officer
2,187 -4.6%
41.98
US$91,819 		2,187 -4.6% 41.98 US$91,819
2026-02-25 2026-02-23 S Sale
Skelton Laurence Matthew

Chief Commercial Officer

Officer
1,582 -2.4%
41.98
US$66,419 		1,582 -2.4% 41.98 US$66,419
2026-02-23 2026-02-23 PrS Proposed sale
LAURENCE SKELTON

Officer

Officer
1,800
42.04
US$75,663 		1,800 42.04 US$75,663
2026-02-23 2026-02-23 PrS Proposed sale
WILLIAM DONALD TURNER

Officer

Officer
2,600
42.04
US$109,291 		2,600 42.04 US$109,291
2026-02-23 2026-02-23 PrS Proposed sale
3.0
SEAN GRANT

Officer

Officer
5,700
42.04
US$239,600 		5,700 42.04 US$239,600
2026-02-23 2026-02-23 PrS Proposed sale
ROBERT BRENNER

Officer

Officer
2,500
42.04
US$105,088 		2,500 42.04 US$105,088
2026-02-23 2026-02-23 PrS Proposed sale
DAVID L JOHNSON

Officer

Officer
2,900
42.04
US$121,902 		2,900 42.04 US$121,902
2026-02-23 2026-02-23 PrS Proposed sale
MARSHALL FORDYCE

Officer

Officer
16,600
42.04
US$697,781 		16,600 42.04 US$697,781
2025-12-17 2025-12-15 PlS Planned sale
Turner William D.

Chief Regulatory Officer

Officer
10,000 -30.8%
50.08
US$500,767 		10,000 -30.8% 50.08 US$500,767
2025-12-15 2025-12-15 PrS Proposed sale
WILLIAM TURNER

Officer

Officer
10,000
49.80
US$498,000 		10,000 49.80 US$498,000
2025-12-15 2025-12-11 B Purchase
3.6
ENRIGHT PATRICK G
Non-Executive Director
5,882 +inf%
42.50
US$249,985 		5,882 +inf% 42.50 US$249,985
2025-12-10 2025-12-08 PlS Planned sale
Turner William D.

Chief Regulatory Officer

Officer
10,000 -30.8%
45.31
US$453,053 		10,000 -30.8% 45.31 US$453,053
2025-12-08 2025-12-08 PrS Proposed sale
WILLIAM TURNER

Officer

Officer
10,000
44.90
US$449,000 		10,000 44.90 US$449,000
2025-12-04 2025-12-03 PlS Planned sale
Turner William D.

Chief Regulatory Officer

Officer
10,000 -30.8%
40.00
US$400,000 		10,000 -30.8% 40.00 US$400,000
2025-11-25 2025-11-21 S Sale
0.5
Carter Jason S

Chief Legal Officer

Officer
3,864 -7.3%
27.82
US$107,498 		3,864 -7.3% 27.82 US$107,498
2025-11-24 2025-11-21 PrS Proposed sale
0.5
Carter Jason S

Officer

Officer
3,864
27.87
US$107,690 		3,864 27.87 US$107,690
2025-11-13 2025-11-11 PlS Planned sale
3.6
Young Joseph R

SVP, FINANCE, CHIEF ACCT OFFCR

Officer
15,000 -23.9%
29.06
US$435,874 		15,000 -23.9% 29.06 US$435,874
2025-06-25 2025-06-24 B Purchase
3.6
ENRIGHT PATRICK G
Non-Executive Director
27,071 +0.8%
22.35
US$605,083 		27,071 +0.8% 22.35 US$605,083
2025-06-25 2025-06-24 B Purchase
3.6
ENRIGHT PATRICK G
Non-Executive Director
13,536 +0.8%
22.35
US$302,553 		13,536 +0.8% 22.35 US$302,553
2025-06-25 2025-06-23 B Purchase
3.6
ENRIGHT PATRICK G
Non-Executive Director
139,595 +4.1%
20.87
US$2,913,110 		139,595 +4.1% 20.87 US$2,913,110
2025-06-25 2025-06-23 B Purchase
3.6
ENRIGHT PATRICK G
Non-Executive Director
69,798 +4.1%
20.87
US$1,456,566 		69,798 +4.1% 20.87 US$1,456,566
2025-02-27 2025-02-26 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,100 -0.5%
28.32
US$31,150 		1,100 -0.5% 28.32 US$31,150
2025-02-27 2025-02-26 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
7,975 -3.7%
27.55
US$219,732 		7,975 -3.7% 27.55 US$219,732
2025-02-26 2025-02-26 PrS Proposed sale
MARSHALL FORDYCE

Director; Officer

Executive Director
9,075
27.10
US$245,932 		9,075 27.10 US$245,932
2025-02-27 2025-02-21 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
10,613 -4.7%
27.89
US$296,032 		10,613 -4.7% 27.89 US$296,032
2025-01-10 2025-01-08 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,875 -1.3%
42.00
US$78,750 		1,875 -1.3% 42.00 US$78,750
2025-01-10 2025-01-08 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
5,650 -3.8%
42.03
US$237,489 		5,650 -3.8% 42.03 US$237,489
2025-01-10 2025-01-08 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
9,975 -6.5%
41.53
US$414,297 		9,975 -6.5% 41.53 US$414,297
2025-01-08 2025-01-08 PrS Proposed sale
MARSHALL FORDYCE

Director; Officer

Executive Director
17,500
42.10
US$736,750 		17,500 42.10 US$736,750
2024-12-20 2024-12-18 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,875 -2.1%
43.81
US$82,144 		1,875 -2.1% 43.81 US$82,144
2024-12-20 2024-12-18 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
4,635 -5.1%
44.03
US$204,094 		4,635 -5.1% 44.03 US$204,094
2024-12-20 2024-12-18 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
5,023 -5.5%
43.52
US$218,609 		5,023 -5.5% 43.52 US$218,609
2024-12-20 2024-12-18 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
2,195 -2.5%
42.35
US$92,949 		2,195 -2.5% 42.35 US$92,949
2024-12-20 2024-12-18 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
3,772 -4.2%
41.33
US$155,883 		3,772 -4.2% 41.33 US$155,883
2024-12-18 2024-12-18 PrS Proposed sale
MARSHALL FORDYCE

Director; Officer

Executive Director
17,500
43.91
US$768,425 		17,500 43.91 US$768,425
2024-12-13 2024-12-11 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
100 -0.1%
47.65
US$4,765 		100 -0.1% 47.65 US$4,765
2024-12-13 2024-12-11 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,775 -2.0%
46.94
US$83,325 		1,775 -2.0% 46.94 US$83,325
2024-12-13 2024-12-11 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
700 -0.8%
47.55
US$33,284 		700 -0.8% 47.55 US$33,284
2024-12-13 2024-12-11 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
14,925 -14.8%
46.91
US$700,150 		14,925 -14.8% 46.91 US$700,150
2024-12-11 2024-12-11 PrS Proposed sale
MARSHALL FORDYCE

Director; Officer

Executive Director
17,500
46.92
US$821,100 		17,500 46.92 US$821,100
2024-11-27 2024-11-25 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,875 -2.1%
49.00
US$91,875 		1,875 -2.1% 49.00 US$91,875
2024-11-27 2024-11-25 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,875 -2.1%
48.76
US$91,425 		1,875 -2.1% 48.76 US$91,425
2024-11-27 2024-11-25 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,381 -1.6%
48.80
US$67,399 		1,381 -1.6% 48.80 US$67,399
2024-11-27 2024-11-25 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
7,665 -8.2%
48.18
US$369,330 		7,665 -8.2% 48.18 US$369,330
2024-11-27 2024-11-25 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
6,579 -7.1%
47.05
US$309,532 		6,579 -7.1% 47.05 US$309,532
2024-11-25 2024-11-25 PrS Proposed sale
MARSHALL FORDYCE

Director; Officer

Executive Director
19,375
48.31
US$936,006 		19,375 48.31 US$936,006
2024-11-15 2024-11-13 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
7,500 -8.0%
49.00
US$367,500 		7,500 -8.0% 49.00 US$367,500
2024-11-15 2024-11-13 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,875 -2.1%
49.50
US$92,811 		1,875 -2.1% 49.50 US$92,811
2024-11-15 2024-11-13 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,875 -2.1%
49.52
US$92,848 		1,875 -2.1% 49.52 US$92,848
2024-11-15 2024-11-13 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,875 -2.1%
49.57
US$92,951 		1,875 -2.1% 49.57 US$92,951
2024-11-15 2024-11-13 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
310 -0.4%
50.35
US$15,609 		310 -0.4% 50.35 US$15,609
2024-11-15 2024-11-13 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
1,565 -1.8%
49.59
US$77,603 		1,565 -1.8% 49.59 US$77,603
2024-11-15 2024-11-13 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
100 -0.1%
51.20
US$5,120 		100 -0.1% 51.20 US$5,120
2024-11-15 2024-11-13 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
3,307 -3.7%
50.28
US$166,281 		3,307 -3.7% 50.28 US$166,281
2024-11-15 2024-11-13 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
12,218 -12.4%
49.54
US$605,314 		12,218 -12.4% 49.54 US$605,314
2024-11-13 2024-11-13 PrS Proposed sale
MARSHALL FORDYCE

Director; Officer

Executive Director
30,625
48.54
US$1,486,538 		30,625 48.54 US$1,486,538
2024-10-30 2024-10-28 PlS Planned sale
3.7
SEIDENBERG BETH C
Non-Executive Director
202 -0.2%
49.54
US$10,007 		202 -0.2% 49.54 US$10,007
2024-10-30 2024-10-28 PlS Planned sale
3.7
SEIDENBERG BETH C
Non-Executive Director
14,798 -10.1%
48.01
US$710,486 		14,798 -10.1% 48.01 US$710,486
2024-10-28 2024-10-28 PrS Proposed sale
3.7
BETH C SEIDENBERG

Director

Non-Executive Director
15,000
41.09
US$616,350 		15,000 41.09 US$616,350
2024-10-25 2024-10-23 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
3,750 -1.2%
42.00
US$157,500 		3,750 -1.2% 42.00 US$157,500
2024-10-25 2024-10-23 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
600 -0.2%
41.61
US$24,968 		600 -0.2% 41.61 US$24,968
2024-10-25 2024-10-23 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
2,310 -0.7%
40.70
US$94,022 		2,310 -0.7% 40.70 US$94,022
2024-10-25 2024-10-23 PlS Planned sale
Fordyce Marshall

PRESIDENT AND CEO

Executive Director
12,715 -4.0%
39.81
US$506,121 		12,715 -4.0% 39.81 US$506,121
Explore more

More insider trading research around Vera Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America